BPG is committed to discovery and dissemination of knowledge
-
|
Homepage
|
-
|
Online Submission
|
- Number of total visits
-
1289837
- Number of visits today
- 427
- Number of downloads
-
875484
MEMBERSHIP
Cited by in F6Publishing
Number |
Citing Articles |
1 |
Su H, Wang X, Song J, Wang Y, Zhao Y, Meng J. MicroRNA-539 inhibits the progression of Wilms' Tumor through downregulation of JAG1 and Notch1/3. Cancer Biomark 2019;24:125-33. [PMID: 30530967 DOI: 10.3233/CBM-181972] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
|
2 |
Yu H, Song H, Ma Z, Ji W. Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer. Open Life Sci 2018;13:497-503. [PMID: 33817119 DOI: 10.1515/biol-2018-0059] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
3 |
Sgarra R, Pegoraro S, D'Angelo D, Ros G, Zanin R, Sgubin M, Petrosino S, Battista S, Manfioletti G. High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network. Int J Mol Sci 2020;21:E717. [PMID: 31979076 DOI: 10.3390/ijms21030717] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
4 |
Cai F, Chen L, Sun Y, He C, Fu D, Tang J. MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1. Biochem Cell Biol 2020;98:426-33. [PMID: 31742423 DOI: 10.1139/bcb-2019-0111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
© 2004-2022 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345